Chargement en cours...
Emerging Variants of Castration-Resistant Prostate Cancer
Metastatic castration resistant prostate cancer (CRPC) is associated with substantial clinical, pathologic, and molecular heterogeneity. Most tumors remain driven by androgen receptor (AR) signaling, which has clinical implications for patient selection for AR-directed approaches. However, histologi...
Enregistré dans:
| Publié dans: | Curr Oncol Rep |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5479409/ https://ncbi.nlm.nih.gov/pubmed/28361223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-017-0593-6 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|